Drug Evaluation
Also known as: Clinical drug trials (procedure)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00051 | Adalimumab | 2 | Withdrawn | 1 |
| DB00065 | Infliximab | 2 | Withdrawn | 1 |
| DB01033 | Mercaptopurine | 2 | Withdrawn | 1 |
| DB00244 | Mesalazine | 2 | Withdrawn | 1 |
| DB00864 | Tacrolimus | 2 | Withdrawn | 1 |